Author details

Full Name

Carla Oliveira

Affiliation

ORCID

Career Start Year

1998

Papers

173

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36600593	Optimising clinical care through <i>CDH1</i>-specific germline variant curation: improvement of clinical assertions and updated curation guidelines.	J Med Genet	2023
36436516	Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.	Lancet Oncol	2023
36620939	Bioinspired human stomach-on-a-chip with like function and architecture.		2023
34871783	Gastric cancer genetic predisposition and clinical presentations: Established heritable causes and potential candidate genes.	Eur J Med Genet	2022
36101425	Epithelial-Mesenchymal Plasticity Induced by Discontinuous Exposure to TGFÎ²1 Promotes Tumour Growth.	Biology (Basel)	2022
36038258	First estimates of diffuse gastric cancer risks for carriers of germline pathogenic variants.	Journal of Medical Genetics	2022
35586191	Upregulation of tRNA-Ser-AGA-2-1 Promotes Malignant Behavior in Normal Bronchial Cells.	Frontiers in Molecular Biosciences	2022
36553480	The Identification of Large Rearrangements Involving Intron 2 of the Gene in Negative and Breast Cancer Susceptibility.		2022
34751446	Comparison of East-Asia and West-Europe cohorts explains disparities in survival outcomes and highlights predictive biomarkers of early gastric cancer aggressiveness.	Int J Cancer	2022
35343351	Advances in the use of 3D colorectal cancer models for novel drug discovery.	Expert Opinion on Drug Discovery	2022
34425242	Cancer predisposition and germline CTNNA1 variants.	European Journal of Medical Genetics	2021
32066632	Redefinition of familial intestinal gastric cancer: clinical and genetic perspectives.	J Med Genet	2021
34066170	Genetic and Epigenetic Alterations of Regulatory Regions in Hereditary and Sporadic Gastric Cancer.	Pharmaceuticals	2021
33898174	A Fast Alternative to Soft Lithography for the Fabrication of Organ-on-a-Chip Elastomeric-Based Devices and Microactuators.	Advanced Science	2021
33724653	Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges.	Mol Oncol	2021
33498681	Immunophenotype of Gastric Tumors Unveils a Pleiotropic Role of Regulatory T Cells in Tumor Development.	Cancers (Basel)	2021
33498669	Engineering Modular Half-Antibody Conjugated Nanoparticles for Targeting CD44v6-Expressing Cancer Cells.	Nanomaterials	2021
33494396	Proteomics Analysis of Gastric Cancer Patients with Diabetes Mellitus.	J Clin Med	2021
32750958	Towards Automatic Protein Co-Expression Quantification in Immunohistochemical TMA Slides.	IEEE J Biomed Health Inform	2021
34572441	CD44v6 High Membranous Expression Is a Predictive Marker of Therapy Response in Gastric Cancer Patients.	Biomedicines	2021
34503274	The <i>CDH1</i> c.1901C>T Variant: A Founder Variant in the Portuguese Population with Severe Impact in mRNA Splicing.	Cancers (Basel)	2021
33327514	Germline Testing in Breast Cancers: Why, When and How?	Cancers	2020
32252293	Expression of CD44v6-Containing Isoforms Influences Cisplatin Response in Gastric Cancer Cells.	Cancers	2020
31570039	Human cells adapt to translational errors by modulating protein synthesis rate and protein turnover.	RNA Biology	2020
32758476	Hereditary diffuse gastric cancer: updated clinical practice guidelines.	Lancet Oncol	2020
32523621	Inherited CDH1 pathogenic variant: is there a place for surveillance of esophageal gastric inlet patch?	Therapeutic Advances in Gastroenterology	2020
32575504	The Dysfunctional Immune System in Common Variable Immunodeficiency Increases the Susceptibility to Gastric Cancer.	Cells	2020
32849808	Gender Differential Transcriptome in Gastric and Thyroid Cancers.	Frontiers in Genetics	2020
32842638	Skipping Exon-v6 from CD44v6-Containing Isoforms Influences Chemotherapy Response and Self-Renewal Capacity of Gastric Cancer Cells.	Cancers	2020
32500879	Effective intracellular delivery of bevacizumab via PEGylated polymeric nanoparticles targeting the CD44v6 receptor in colon cancer cells.	Biomaterials Science	2020
30989426	Hereditary gastric cancer: what's new? Update 2013-2018.	Fam Cancer	2019
31881796	Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the -- Axis in Diffuse Gastric Cancer.	Cancers	2019
31767037	S100P is a molecular determinant of E-cadherin function in gastric cancer.	Cell Commun Signal	2019
30642281	CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.	BMC Cancer	2019
29779068	New insights into the inflamed tumor immune microenvironment of gastric cancer with lymphoid stroma: from morphology and digital analysis to gene expression.	Gastric Cancer	2019
31141946	Gastric Cancer Extracellular Vesicles Tune the Migration and Invasion of Epithelial and Mesenchymal Cells in a Histotype-Dependent Manner.	International Journal of Molecular Sciences	2019
30909497	CD44s Assembles Hyaluronan Coat on Filopodia and Extracellular Vesicles and Induces Tumorigenicity of MKN74 Gastric Carcinoma Cells.	Cells	2019
31316092	Gene Expression Analyses in Non Muscle Invasive Bladder Cancer Reveals a Role for Alternative Splicing and Tp53 Status.	Scientific Reports	2019
30828519	3D Cellular Architecture Affects MicroRNA and Protein Cargo of Extracellular Vesicles.	Advanced Science	2019
31514334	Multigene Panel Testing Increases the Number of Loci Associated with Gastric Cancer Predisposition.	Cancers	2019
31463414	Genetics of gastric cancer: what do we know about the genetic risks?	Transl Gastroenterol Hepatol	2019
29454568	Phenotypic heterogeneity of hereditary diffuse gastric cancer: report of a family with early-onset disease.	Gastrointest Endosc	2018
28618420	Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications.	Pathobiology	2018
28789584	Monoclonal antibodies: technologies for early discovery and engineering.	Critical Reviews in Biotechnology	2018
30311375	Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants.	Hum Mutat	2018
30267881	Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6.		2018
30308252	Bioengineering a novel 3D in vitro model of gastric mucosa for stomach permeability studies.		2018
30018250	The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors.	Int J Mol Sci	2018
29879907	Targeting miR-9 in gastric cancer cells using locked nucleic acid oligonucleotides.	BMC Molecular Biology	2018
30014492	Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management.	Histopathology	2018